ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 97 filers reported holding ALDEYRA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $417,570 | -16.3% | 62,512 | +5.1% | 0.00% | -100.0% |
| Q2 2023 | $499,154 | +135.4% | 59,494 | +25.0% | 0.00% | – |
| Q1 2022 | $212,000 | +24.7% | 47,596 | +11.7% | 0.00% | – |
| Q4 2021 | $170,000 | -55.5% | 42,600 | -2.0% | 0.00% | -100.0% |
| Q3 2021 | $382,000 | -18.9% | 43,453 | +4.6% | 0.00% | 0.0% |
| Q2 2021 | $471,000 | +519.7% | 41,530 | +34.9% | 0.00% | – |
| Q1 2020 | $76,000 | -57.5% | 30,784 | 0.0% | 0.00% | – |
| Q4 2019 | $179,000 | +11.2% | 30,784 | +0.5% | 0.00% | – |
| Q3 2019 | $161,000 | -10.6% | 30,641 | +2.4% | 0.00% | – |
| Q2 2019 | $180,000 | -26.5% | 29,935 | +10.1% | 0.00% | – |
| Q1 2019 | $245,000 | +27.6% | 27,183 | +17.3% | 0.00% | – |
| Q4 2018 | $192,000 | 0.0% | 23,173 | +66.6% | 0.00% | – |
| Q3 2018 | $192,000 | +69.9% | 13,913 | -2.4% | 0.00% | – |
| Q2 2018 | $113,000 | – | 14,256 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 908,488 | $6,232,000 | 2.88% |
| Knoll Capital Management, LLC | 569,405 | $3,906,000 | 2.66% |
| Mesirow Financial Investment Management, Inc. | 64,698 | $443,828,000 | 1.40% |
| Ghost Tree Capital, LLC | 650,000 | $4,459,000 | 0.99% |
| Johnson & Johnson Innovation - JJDC, Inc. | 594,834 | $4,081,000 | 0.53% |
| Perceptive Advisors | 6,285,458 | $43,118,000 | 0.46% |
| Affinity Asset Advisors, LLC | 100,000 | $686,000 | 0.36% |
| ACUTA CAPITAL PARTNERS, LLC | 192,500 | $1,321,000 | 0.36% |
| Avidity Partners Management LP | 1,435,000 | $9,844,000 | 0.32% |
| APOGEM CAPITAL LLC | 55,821 | $383,000 | 0.26% |